Government control has driven health care costs sky-high at the same time that it has reduced the quality of care. As America's health care system cries out for reform, should policymakers embrace even more government planning, or should they fight for more individual freedom? In this updated edition of their 2005 book, the authors tackle proposals that would let government manage even more of America's health care sector. The continuing problem of ever-rising health care costs makes this book as timely as ever.
The Patient Protection and Affordable Care Act (PPACA) remains vulnerable to repeal, largely because Congress and the Supreme Court have granted each state the power to veto major provisions of the law before they take effect in 2014. The PPACA itself empowers states to block the employer mandate, to exempt many of their low- and middle-income taxpayers from the individual mandate, and to reduce federal deficit spending, simply by not establishing a health insurance "exchange." To date, 34 states have refused to create Exchanges and some 16 states have announced they would not expand their Medicaid programs. Yet the Obama administration is trying to coerce states into implementing parts of the expansion that the Court rendered optional. This special White Paper provides a comprehensive review of the process now occurring between states and the Obama Administration, underscoring how a critical mass of states exercising their vetoes over Exchanges and the Medicaid expansion can force Congress to reconsider, and hopefully repeal, the rest of the PPACA.
A quick‐reference guide to reforms that state and federal policymakers must enact to make health care better, more affordable, more secure, and more universal. Health care in the United States is not a free market. In many ways, U.S. residents are less free to make their own health decisions than residents of other nations. Government controls a larger share of health spending in the United States than in Canada, the United Kingdom, and most other advanced nations. State and federal governments subsidize low‐quality medical care and penalize high‐quality care. They block innovations that would otherwise reduce medical prices. Congress even funds veterans benefits in a way that increases the likelihood of war. Fortunately, there are corners of the U.S. health sector where market forces have had room to breathe. In those areas, markets have made health care better, more affordable, and more secure. They have made health care more universal-both in the United States and in nations that supposedly already had universal health care. Sometimes, market forces develop such innovations despite government policies that exist explicitly to block them. Those sorts of innovations should be exploding across the United States and the world, bringing affordable health care to low‐income patients and driving high‐cost and low‐quality providers and insurers out of business. But they aren't. Recovery shows that making health care as universal as possible requires ending all barriers that government places in the way of better, more affordable, and more secure health care.
First published in 1986 under the editorial direction of Dr. Henry J.M. Barnett, Stroke: Pathophysiology, Diagnosis, and Management continues to provide the dependable, current answers you need to effectively combat the increasing incidence of this disease. Dr. J.P. Mohr, together with new associate editors Philip A. Wolf, James C. Grotta, Michael A. Moskowitz, Marc Mayberg, and Rüdiger von Kummer as well as a multitude of expert contributors from around the world, offer you updated and expanded coverage of mechanisms of action of commonly used drugs, neuronal angiogenesis and stem cells, basic mechanisms of spasm and hemorrhage, prevention of stroke, genetics/predisposing risk factors, and much more, equipping you to understand the latest scientific discoveries and make effective use of the newest approaches to diagnosis and treatment. Gain fresh perspectives and up-to-date insights from the world’s leading authorities on the pathophysiology, diagnosis, and management of stroke. Access the comprehensive, expert clinical guidance you need to recognize the clinical manifestations of stroke, use the latest laboratory and imaging studies to arrive at a diagnosis, and generate an effective medical and surgical treatment plan. Make efficient and accurate diagnoses with the aid of abundant full-color CT images and pathology slides. Stay up to date on hot topics such as mechanisms of action of commonly used drugs, neuronal angiogenesis and stem cells, basic mechanisms of spasm and hemorrhage, prevention of stroke, genetics/predisposing risk factors, and much more.
This newly updated edition is a compilation of readings, divided into nine sections, each examining a specific hotel department or activity. Each topic is examined through a variety of viewpoints on the duties, responsibilities, problems, and opportunities encountered there. Multidimensional case studies, taking a practical approach, challenge readers to identify the central issues involved in complex management problems, understand the structure and resources of the department in question, and find solutions that may help in managing other hotel resources and departments.
Covering the latest advances in CNS drug development, this bookwill guide all those involved in pre-clinical to early clinicaltrials. The authors describe how recent innovations can acceleratethe development of novel CNS compounds, improve early detection ofefficacy and toxicity signals, and increase the safety oflater-stage clinical trials. The current crisis in the drug development industry iscritically reviewed, as well as the steps needed to correct theproblems, including new government-backed regulations andindustry-based innovations designed to accelerate CNS drugdevelopment in the future. Animal-based models of major CNS disorders are described indetail, and the ability of the latest in vitro and computer-basedmodels to simulate CNS disease states and predict drug efficacy andside-effects are examined. Particular attention is given tothe growing use of biomarkers and how they can be used effectivelyin early human trials as signals of potential drug efficacy, aswell as the increasingly important role of imaging studies to guidedose selection. Cognitive assessments that can be useful indicatorsof effect in patient populations are also discussed. Written by a team of clinical scientists involved in CNS drugtrials for over 20 years, and based on a wealth of drug developmentand clinical trial experience, Critical Pathways to Success inCNS Drug Developmentis full of practical advice forsuccessfully designing and executing CNS drug trials, avoidingpotential pitfalls, and complying with government regulations
Easy Access is the only handbook organized by the types of help student writers need. Part One (red tabs) provides a guide to writing processes and products. Solutions to common writing problems and ESL troublespots are found in Part Two (blue tab). Part Three (yellow tab) offers alphabetically organized definitions and examples of grammar, mechanics, and punctuation terms.
Part 1 of this edition consists of the creation of the English football league in 1888. It includes every football league result and the final league tables to the first England International matches in the British Home International Championship results. It also provides the tables and their statistics with the first games against overseas opposition, containing all the players and their teams. Read about the oldest cup competition in the world, the Football Association Challenge Cup (FA Cup), from its humble beginning in 1872 and every result from the first round until the final. The book also incorporates the First World War mini-tournaments to the first FA Cup Final and England Internationals played at the World famous British Empire Stadium, simply known as Wembley Stadium. Part 1 finishes with the 1929-1930 football league season. Amaze your friends with the facts! For history buffs and true sportsmen, The History of the English Football League - Part 1: 1888-1930 is a must read.
America's health care system is at a crossroads, faced with rising costs, quality concerns, and a lack of patient control. Some blame market forces. Yet many troubles can be traced directly to pervasive government influence: entitlements, tax laws, and costly regulations. Consumer choice and competition deliver higher quality and lower prices in other areas of the economy. The authors conclude that removing restrictions can do the same for health care. In the newly updated edition, the authors expand on their prior work with new analysis of the best and worst ideas in health care reform – on both the right and the left.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.